Ireland· IE-PA-PA1436/001/002
Mirtazapine Bluefish 30 mg orodispersible tablets
A mirtazapine product containing mirtazapine, registered in Ireland by Bluefish Pharmaceuticals AB. The same ATC class is registered in 18 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Mirtazapine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06AX11 (mirtazapine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 11 of them publish a price we can compare per daily dose
Mirtazapine · ATC N06AX11
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mirtazapine costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.22 in France to $1.40 in Switzerland — a ×6.4 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mirtazapine · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.40
- IT Italy$0.61
- FR France$0.22
The record
At a glance
HPRA (Ireland)- Active substance
- Mirtazapine
- Manufacturer
- Bluefish Pharmaceuticals AB
- Country
- Ireland (IE)
- ATC code
- N06AX11
- ATC class
- Mirtazapine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1436/001/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
482 interactions on record for mirtazapine.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mirtazapine · interactions on record
482 records
- 50 severe
- 234 moderate
- 2 minor
- 162 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
34 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mirtazapine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFinamedNucleus ehf
- United KingdomMirtazapine 30mg orodispersible tabletsBluefish Pharmaceuticals AB
- SpainMIRTAZAPINA APOTEX 30 mg COMPRIMIDOS BUCODISPERSABLES EFGApotex Europe B.V.
- PolandAuroMirta OROAurovitas Pharma Polska Sp. z o.o.
- ItalyMIRTAZAPINA ALMUSALMUS S.R.L.
- BelgiumMirtazapine AB 30 mgAurobindo
- United StatesMirtazapineBryant Ranch Prepack
- SwitzerlandMirtazapin Sandoz eco 30 mg, SchmelztablettenSandoz Pharmaceuticals AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Mirtabene, Mirtabene Ratiopharm Gmbh
- Belgium · Mirtazapine Ab, Mirtazapine Eg
- Bulgaria · Мирзатен, Мирзатен Q-Tab
- Cyprus · Mirtazapin Aurobindo, Remeron
- Czechia · Miranox, Mirtazapin +pharma
- Germany · Mirta, Mirta Tad
- Denmark · Combar, Mirtazapin "hexal"
- Estonia · Mirtastad, Mirtazapin Actavis
- Spain · Afloyan, Mirtazapina Almus
- Finland · Mirtazapin Actavis, Mirtazapin Grindeks
- France · Mirtazapine Almus, Mirtazapine Arrow
- United Kingdom (Northern Ireland) · Mirtazapine, Mirtazapine Accord Healthcare
- Greece · Anchopriv, Azapin
- Croatia · Calixta, Mirtazapin Genericon
- Hungary · Mirtadepi, Mirtastad
- Iceland · Míron, Miron Smelt
- Italy · Mirtazapin Grindeks, Mirtazapina Almus
- Lithuania · Mirtazapin Actavis, Mirtazapin Grindeks
- Luxembourg · Mirtazapin Ratiopharm, Mirtazapine Eg
- Latvia · Mirtastad, Mirtazapine Grindeks
- Malta · Mirap, Mirap Distab
- Netherlands · Mirtazapine Amarox, Mirtazapine Aurobindo
- Norway · Mirtazapin Actavis, Mirtazapin Bluefish
- Poland · Auromirta Oro, Mirtagen
- Portugal · Mirtazapin Grindeks, Mirtazapina Almus
- Romania · Mirtazapin Arena, Mirtazapină Aurobindo
- Sweden · Mirtazapin Actavis, Mirtazapin Alternova
- Slovenia · Mirtazapin Grindeks, Mirtazapine Grindeks
- Slovakia · Mirzaten, Mirzaten Q-Tab
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4503012-3a55-4cfd-a980-dffbffdede46 GET /v1/drugs/b4503012-3a55-4cfd-a980-dffbffdede46?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Orodispersible tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"N06AX",
"N06AX11"
],
"strength": null,
"pa_number": "PA1436/001/002",
"substances": [
"Mirtazapine"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "25/04/2008",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0061-033-015"
}See everything about mirtazapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.